Quality Investor
About 

Allient Inc.

Rank #221Capital Return

ALNT · Nasdaq · Technology

Allient Inc. (ALNT) — Rank #221 by gross profitability (GP/assets 0.31) · ROE 7.1% · Piotroski F-Score 7 / 9.

As-of 2026-09-15 · CIK 0000046129 · all metrics point-in-time as of the filing date.

About

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty-controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and the Asia-Pacific.

Show more

The company offers various products and solutions, including nano precision positioning systems; servo control systems; motion controllers; digital servo amplifiers and drives; brushless servo; torque; coreless motors, brush motors, integrated motor-drives, gear motors, gearing, incremental and absolute optical encoders, and active electronic and passive magnetic filters for power quality and harmonic issues; industrial safety rated input/output modules; universal industrial communications gateways; and light-weighting technologies and other controlled motion-related products. It sells its products in industrial, vehicle, medical, and aerospace and defense markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc.

was founded in 1939 and is headquartered in Amherst, New York.

Industry
Electronic Components
Sector
Technology
State
CO
Filer Category
Accelerated filer
Fiscal Year End
December 31

Price History

ALNT+182.8% · +23.1% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

$1.54B

P/E (annual)

68.4

P/S (annual)

2.8

P/B

4.9

P/OCF (annual)

27.1

Shareholder Yield

-0.6%

Employees

2,478

Industry

Electronic Components

Exchange

Nasdaq

Signal Flags

4 green
Revenue growth acceleratingGrowth rate increasing year over year
Operating leverage expandingOperating income growing faster than revenue
Deferred revenue growingRevenue and deferred revenue both growing — retention signal
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak

Quality Profile

Profitability

1/1 pass
GP / assets
0.31
Return on equity
7.1%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.90
Current ratio
3.42×
Net cash
-$131.25M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
0.6%

Growth

2/2 pass
Revenue growth
4.6%
Piotroski F-Score
7 / 9
Share dilution
0.8%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

1 of 5 threshold not computable from filed data.

What Growth Is Priced In

Implied revenue growth (10Y)

13.4%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 0.8% — per-share value needs a total required return of 14.2% once share-count change is priced in.

vs. own 6-year median revenue growth: 7.3%

priced above its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

8.8%

r = 10% (base)

13.4%

r = 12%

17.4%

Net debt / market cap: 8.7%

Note: current FCF margin is 1.7σ above its historical mean — implied growth may understate valuation risk if the margin reverts.

Base FCF: $49.7M3Y mean FCF: $38.4M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

47.0xExpensive
11.8xmed 24.9x47.0x

P / S

Price / revenue per share

1.9xExpensive
0.5xmed 0.9x1.9x

P / B

Price / book value per share

3.4xExpensive
1.5xmed 2.6x3.5x

P / GP

Price / gross profit per share

5.7xExpensive
1.8xmed 3.1x5.7x

P / FCF

Price / free cash flow per share

20.9xFair
10.2xmed 19.5x83.5x

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.31

Primary signal (Novy-Marx).

44th pctl of 37 SIC 38 peers

Return on equity

7.1%

Gross margin

32.8%

14th pctl of 37 SIC 38 peers

Revenue growth (YoY)

4.6%

RPO growth (YoY)

0.9%

Remaining performance obligations growth — RPO > revenue = forward demand building.

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

3.3%

Revenue CAGR (5Y)

8.6%

Earnings CAGR (3Y)

8.2%

FCF CAGR (3Y)

—

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.90

50th pctl of 35 SIC 38 peers (best = lowest)

Current ratio

3.42×

74th pctl of 36 SIC 38 peers

Quick ratio

1.77×

Net cash

-$131.25M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$49.69M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

1.25

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.6%

Stock-based comp intensity.

Dividend safety

Composite score

3.8 / 5

Good
Payout ratio
9.1%5/5 Strong
FCF coverage
24.83×5/5 Strong
Dividend growth streak
5 yr3/5 Good
Balance-sheet health
D/E 0.90 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

7 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20202025
Value
Capital Return
Op. Leverage
Decline
View full financial statements →